VanNess & VanNess, P.A.

Posts tagged "Mesothelioma Clinical Trials Attorneys"

New Drug Defactinib trials underway to treat mesothelioma by targeted killing of cancer cells.

A new cancer drug, Defactinib (VS-6033), is an orally administered compound designed to target and kill cancer cells in mesothelioma patients. The clinical trial named COMMAND (Control of Mesothelioma and Maintenance Defactinib) is a global clinical trial involving the U.S., U.K., Japan, Australia and other European countries and is expected to enroll between 350-400 patients to determine the effectiveness of VS-6033 for Mesothelioma patients. Mesothelioma is an aggressive form of cancer caused by exposure to asbestos.

Email Us For A Response

Discuss Your Case With An Experienced Attorney

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

Office Location

1205 N. Meeting Tree Blvd.
Crystal River, FL 34429

Toll Free: 866-697-6221
Phone: 352-436-4333
Crystal River Law Office Map

250 International Parkway
Suite 340
Lake Mary, Florida 32746

Toll Free: 866-697-6221
Phone: 352-436-4333
Map & Directions

Office Location